Capacitive-resistive monopolar radiofrequency

Capacitive-resistive monopolar radiofrequency has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 10, 2026: “Efficacy of nonablative radiofrequency on sexual function in postmenopausal women: a randomized clinical trial”.

Intervention

1 paper studies it3 findingsUpdated

See all 1 papers on capacitive-resistive monopolar radiofrequency

At a glance

The findings reach people, from one lab or study. 1 lab in 1 country.

“the intervention group showed significantly greater improvements in the Female Sexual Function Index and Vaginal Health Index at post-treatment and at the 12-week follow-up.”
Efficacy of nonablative radiofrequency on sexual function in postmenopausal women: a randomized clinical trialMenopause (New York, N.Y.)2026doi:10.1097/gme.0000000000002743

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 1 lab in 1 country
  • Human trial1

Studies in people

1 study gave capacitive-resistive monopolar radiofrequency to people and measured what changed.

What changedDesignPeopleSource

up: Improves Female Sexual Function IndexCohen's d >0.77, 95% CI, 0.25-1.29

up: Improves Vaginal Health Indexd >3.49, 95% CI, 2.68-4.28

no change: Has no effect on vaginal cytology

Randomized trialpost-treatment and 12-week follow-upWomenPostmenopausal women; genitourinary syndrome of menopauseMenopause (New York, N.Y.), Feb 10, 2026

What did studies of capacitive-resistive monopolar radiofrequency find?

3

Studies of capacitive-resistive monopolar radiofrequency measured 3 outcomes: vaginal cytology, Vaginal Health Index and Female Sexual Function Index.

Vaginal cytology

no changein humans1

1 study
  1. Capacitive-resistive monopolar radiofrequency showed no clear effect on vaginal cytology in humans (genitourinary syndrome of menopause).

    Human trialgenitourinary syndrome of menopausevaginasix weekly sessionspost-treatment and 12-week follow-upfemales

More on Vaginal cytology

Vaginal Health Index

upin humans1

1 study
  1. Capacitive-resistive monopolar radiofrequency improves Vaginal Health Index in humans (genitourinary syndrome of menopause) (d >3.49, 95% CI, 2.68-4.28).

    Human trialgenitourinary syndrome of menopausevaginasix weekly sessionspost-treatment and 12-week follow-upfemales

More on Vaginal Health Index

Female Sexual Function Index

upin humans1

1 study
  1. Capacitive-resistive monopolar radiofrequency improves Female Sexual Function Index in humans (genitourinary syndrome of menopause) (Cohen's d >0.77, 95% CI, 0.25-1.29).

    Human trialgenitourinary syndrome of menopausevaginasix weekly sessionspost-treatment and 12-week follow-upfemales

More on Female Sexual Function Index

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months